At a glance
ClinicalIndex Comparison RecordN/ACompleted· 113 enrolled
Drug / intervention
Nasal Implantdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Spirox Latera™ Implant Support of Lateral Nasal Wall Cartilage (LATERAL-OR) Study
In Brief
A clinical study evaluating Nasal Implant for Nasal Obstruction. Completed, enrolled 113 participants across 12 sites.
Detailed Summary
This study is being conducted to obtain outcomes data in subjects with severe to extreme class NOSE scores undergoing placement of the Spirox Latera Implant with or without concurrent septoplasty and/or turbinate reduction procedures in an operating room setting.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNasal Obstruction
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartSep 2016
First PostedNov 2016
Primary CompletionMar 2018
Study CompletionAug 2019
TodayJul 2026
First PostedNov 2, 2016
Enrollment StartSep 1, 2016
Primary CompletionMar 1, 2018
Study CompletionAug 1, 2019
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 9.7 years ago
Interventions
Nasal Implantdevice